ProBioGen AG Tech Stack

GMP contract manufacturing and cell line development for biologics

Biotechnology Research Berlin 201–500 employees Founded 1994 Public Company

ProBioGen operates three manufacturing lines in Berlin serving biopharmaceutical clients with cell line engineering, process development, and GMP-certified manufacturing. The tech stack (SAP, JMP, Azure, AWS, Python, Prometheus) reflects operational maturity in data capture and cloud infrastructure, while hiring velocity is accelerating with a 10-to-3 manufacturing-to-engineering ratio — indicating scaling of production capacity rather than platform innovation. Pain points cluster around GMP compliance, process transfer friction, and maintenance optimization, suggesting the company is managing high-complexity regulatory manufacturing at operational limits.

Tech Stack 16 technologies

Core StackSAP AWS Cisco Fortinet Terraform Ansible Python Grafana Prometheus CloudWatch rexx JMP Azure GCP Aruba PowerShell

What ProBioGen AG Is Building

◆Challenges

Ensuring gmp compliance
Optimizing internal maintenance strategies
Managing spare parts inventory
Process deviations
Process transfer
Gap risk assessments
Optimizing method validation after handover
Ensuring device functionality
Maintaining gmp compliance
Optimizing recruiting processes

▲Active Projects

Optimizing internal maintenance strategies
Planning and scheduling external service providers
Viral vector downstream processing
Process transfer to gmp production
Maintenance projects
Service projects
Renovation projects
Method validation after handover
Gmp documentation
External audit coordination

Hiring Activity

Accelerating15 roles · 10 in 30d

Department

Manufacturing

Engineering

Ops

Quality

Seniority

Mid

Junior

Lead

Intern

Company intelligence

Find more companies like ProBioGen AG by tech stack, pain points and active projects

Get started free

About ProBioGen AG

ProBioGen is a public contract development and manufacturing organization (CDMO) based in Berlin, founded in 1994 as a Charité spin-off. The company serves biopharmaceutical and biotech firms across three core service areas: cell line development (including proprietary AGE1® producer cell lines), process development and scale-up, and GMP manufacturing of proteins, antibodies, viral vectors, and vaccines. The organization operates three manufacturing facilities in Berlin and employs approximately 300 people. Revenue model is project-based CDMO contracting with embedded analytical services and technology licensing for proprietary platforms (DirectedLuck® transposase, GlymaxX® afucosylation).

HeadquartersBerlin

Company Size201–500 employees

Founded1994

Hiring MarketsGermany

Frequently Asked Questions

What is ProBioGen's manufacturing capacity?

ProBioGen operates three GMP manufacturing lines in Berlin. The company offers both GMP and non-GMP cell line manufacturing, process development, and downstream processing services for proteins, antibodies, viral vectors, and vaccines.

What proprietary technologies does ProBioGen offer?

ProBioGen owns three proprietary platforms: AGE1® producer cell lines for mammalian expression, DirectedLuck® transposase technology for cell line engineering, and GlymaxX® afucosylation technology for antibody optimization.

How this profile is built

ProBioGen AG's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.